#94 Design, synthesis and characterization of a series of 6-substituted-4-hydroxy-1-(2-substitutedthiazol-4-yl)quinolin-2(1H)-one derivatives and evaluation of their in-vitro anticancer and antibacterial activity

Keywords

aaa

How to Cite

(1)
Phadte, S. .; Bheemanagauda, B. .; Chandavarkar, S. .; Desai, S. M. .; Naik, S. .; Tiwari, P. . #94 Design, Synthesis and Characterization of a Series of 6-Substituted-4-Hydroxy-1-(2-Substitutedthiazol-4-yl)quinolin-2(1H)-One Derivatives and Evaluation of Their in-Vitro Anticancer and Antibacterial Activity. J Pharm Chem 2022, 8.

Abstract

The research work deals with the design, synthesis, and characterization of a series of 6substituted-4-hydroxy-1-(2-substituted thiazole-4-yl)-quinoline-2(1H)-one derivative [III(a-d)(1-3)] and evaluation of their in vitro anticancer activity against MDA-MB (Breast cancer) and A549 (Lung cancer) cell lines. A series of substituted thiazole-4-yl-quinolin-2(1H)-one derivative [III(a-d)(1-3)] were synthesized from starting material, substituted 4-hydroxyquinoline-2(1H)-ones I(a-d) as per the literature. Compounds I (a-d) were further subjected to condensation with chloroacetyl chloride to obtain 6-substituted-1-(2-chloroacetyl)-4-hydroxyquinoline-2(1H)-ones II (a-d). Finally, condensation with thiourea or thiamide through Hantzsch’s thiazole synthesis yields twelve derivatives of 6-substituted4-hydroxy-1-(2-substituted thiazole-4-yl)quinoline-2(1H)-ones [III(a-d)(1-3)]. The synthesized derivatives were characterized by spectral analysis. They were tested for their in vitro anticancer activity against MDA-MB (Breast cancer) and A549 (Lung cancer) cell lines by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay method. Molecular docking studies of the synthesized compounds exhibited well-conserved hydrogen bond interactions with one or more amino acid residues in the EGFRK tyrosine kinase domain (PDB ID: 1M17) for docking study on anticancer activity. The compounds were tested for their in vitro anticancer activity against MDA-MB (Breast cancer) and A549 (Lung cancer) cell lines at 31.25, 62.5, 125, 250, and 500 µg/mL concentration using the MTT assay method. All synthesized derivatives were potent against the A549 (Lung cancer) cell line compared to the MDA-MB (Breast cancer) cell line. Compound 6-fluoro-4-hydroxy-1-(2-phenylthiazol-4-yl)-quinoline-2(1H)-one (IIIc-3) exhibited the highest MolDock score (-102.535), which was comparable to that shown by the standard Imatinib (-116.362) for anticancer docking and was found to be the most cytotoxic as compared to the other synthesized derivatives, with IC50 values of 397.56 μg/mL against A549 (Lung cancer) cell line. The synthesized derivatives showed good activity compared to the standard drug and hence possessed a potential to bind with some of the residues of the active site and can be further developed into potential pharmacological agents.

References

aaa

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Copyright (c) 2022 Journal of Pharmaceutical Chemistry